Activation of phosphoinositide breakdown and elevation of intracellular calcium in a rat RBL-2H3 mast cell line by adenosine analogs: Involvement of A3-adenosine receptors?

Drug Development Research

Volumn 39, Issue 1, 1996, Pages 36-46

  Shin, Yangmee ^a   Daly, John W ^a   Jacobson, Kenneth A ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adenosine receptors; Calcium; Phosphoinositides; Xanthines

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 6 N BENZYLADENOSINE; 8 BROMOADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CYCLOHEXYLADENOSINE; MRS 1067; PHENYLISOPROPYLADENOSINE; PHOSPHATIDYLINOSITIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CONTROLLED STUDY; IN VITRO STUDY; MAST CELL; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; RAT;

EID: 0030497573     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(19960901)39:1<36::AID-DDR5>3.0.CO;2-L     Document Type: Article

References (18)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. Ali H, Cunha-Melo JR, Saul WF, Beaven MA (1990): Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. J Biol Chem 265:745-753.
3. 3 receptors in mast cells. Trends Pharmacol Sci 15:13-14.
4. Berridge MJ, Dawson RM, Dowries CP, Heslop JP, Irvine RF (1983): Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 212:473-482.
5. Choi OH, Kim J-H, Kinet J-P (1996): Calcium mobilization via sphingosine kinase in signaling by the FcRI antigen receptor. Nature 380:634-636.
6. 3-selective adenosine agonists. J Med Chem 37:636-646.
7. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
8. 3 adenosine receptors: Design of selective ligands and therapeutic prospects. Drugs Future 20:689-699.
9. 3 adenosine receptors. Biochem Biophys Res Commun 203:570-576.
10. 3 adenosine receptor antagonists. J Med Chem 39:2293-2301.
11. 3-adenosine receptors. J Med Chem 37:3614-3621.
12. 3-adenosine receptors: Structure-activity relationships of 1,3-dialkylxanthine-7-riboside derivatives. J Med Chem 37:4020-4030.
13. Marquardt DL (1988): Adenosine and mast cell secretion. In Cooper DMF, Londos C (eds): Adenosine Receptors. New York: Alan R. Liss, pp 87-95.
14. Marquardt DL, Walker LL (1989): Pretreatment with phorbol esters abrogates mast cell adenosine responsiveness. J Immunol 142:1268-1273.
15. Marquardt DL, Walker LL (1994): Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness. Agents Actions 43:7-12.
16. Marquardt DL, Walker LC, Heinemann S (1994): Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152:4508-4515.
17. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
18. 3 adenosine receptor. Mol Pharmacol 45:1101-1111.